40 research outputs found
Congenital heart defects in children of Chelyabinsk: regional aspects of the 20-year monitoring
The problem of congenital heart defects (CHD) in children, it is determined not only by a severe course, early development of disability, high-cost methods of treatment, but also by regional peculiarities. On the basis of the register of CHD in children in Chelyabinsk, the monitoring of prevalence and morbidity indicators from 2000 to 2020, calculated per 1000 childrenβs population, taking into account its average number, was carried out. During the analyzed period, there was an almost 3-fold increase in the total number of children with CHD: from 691 people in 2000 to 1903 people in 2020. A stable growth of this pathology was revealed in the first year of their life: 3.9 % in 2000, 11.0 % in 2012, 12.3 % in 2020.The prevalence and primary incidence of CHD over the past 20 years have been characterized by a steady increase: from3.68 and 0.72 in 2000 to 8.04 and 1.48 in 2020, respectively. Septal defects and open ductus arteriosus occupy leading positions in the structure of all CHD, accounting for 61 % in 2000 and 74 % in 2020. An increase in the number of early surgical interventions, especially during the first year of a childβs life (from 11 % in 2000 up to 31 % in 2020) is associated with a decrease in disability (from 15.7 % in 2000 to 4.8 % in 2020). Monitoring of registry data, especially at the regional level, can be a useful mechanism for assessing the situation of CHD, monitoring the effectiveness of both conservative and cardiac surgical treatment
ΠΠΎΡΡΠΎΠ»ΠΎΠ³ΠΎ-Π°Π½Π°ΡΠΎΠΌΡΡΠ½Π΅ Π²ΠΈΠ²ΡΠ΅Π½Π½Ρ Π»ΠΈΡΡΡ Rhododendron luteum sweet
Topicality. Rhododendrons are one of the most popular plants that are widely cultivated in most European countries as ornamental, essential oil, honey and insecticidal plants. Rhododendron luteum Sweet is a polymorphic species found in Ukraine as a wild-growing and ornamental plant. The chemical composition of yellow rhododendron is represented mainly by essential oils, flavonoids, hydroxycinnamic and organic acids, and triterpene and coumarin substances. Leaves are widely used in folk medicine as a diuretic, diaphoretic, astringent, wound healing, anti-inflammatory and analgesic. As a result of the study of the morphological and anatomical structure of the yellow rhododendron leaves, its structurally foliar characters under the conditions of this ecotype growth in Ukraine were studied according to a preliminary analysis of published data. Our studies were carried out with the aim of using macroscopic and microscopic traits of leaves of this species to standardize medicinal plant materials and develop quality control methods.Aim. To identify the leaves of Rhododendron luteum (L.) Sweet by macro and microscopic characteristics. Set the main diagnostic signs of leaves.Materials and methods. The objects of the study were samples of yellow rhododendron leaves collected during the mass flowering period. Microscopicstudies were performed on raw materials fixed in a mixture ofΒ alcohol-glycerolwater (1 : 1 : 1). We used an OLYMPUS Lens FE-140 camera, an MBI-6 microscope, and a Biola-M microscope.Results and discussion. The main morphological and anatomical signs of yellow rhododendron leaves were determined. Macroscopic features include simple short-leaved leaves with a leathery, hollow leaf blade, with a solid edge, a pointed tip, a wedge-shaped base, cirrus venation; microscopic is dorsoventrally type of leaf blade structure. The cells of the upper epidermis are large, thin-walled, sinuous, without stomata, covered with a thick layer of cutin; cells of the lower epidermis are slightly tortuous; stomatal apparatus of the paracitic type, typical of the abaxial epiderm, covering and glandular trichomes are present. Ferruginous club-shaped emergenes on a multicellular stand, the cells of which accumulate a yellowish-brown secretion, the secreting head is oval-cylindrical, multicellular, with dark contents. Covering hairs is of three varieties: 1-2-cell, long, curled, spiky prevail, straight-walled hairs with an expanded base and long, straight-walled, thin-walled hairs are less common. The cut is round-triangular in cross section, the angular collenchyma is underlying the epidermis; in parenchymal cells, frequent crystals of calcium oxalate - druses and prismatic crystals.Conclusions. The results of macroscopic and microscopic study characteristics of yellow rhododendron leaves will be used to standardize medicinal plant materials and develop quality control methods.ΠΠΊΡΡΠ°Π»ΡΠ½ΠΎΡΡΡ. Π ΠΎΠ΄ΠΎΠ΄Π΅Π½Π΄ΡΠΎΠ½Ρ ΡΠ²Π»ΡΡΡΡΡ ΠΎΠ΄Π½ΠΈΠΌΠΈ ΠΈΠ· ΠΏΠΎΠΏΡΠ»ΡΡΠ½Π΅ΠΉΡΠΈΡ
ΡΠ°ΡΡΠ΅Π½ΠΈΠΉ, ΠΊΠΎΡΠΎΡΡΠ΅ ΡΠΈΡΠΎΠΊΠΎ ΠΊΡΠ»ΡΡΠΈΠ²ΠΈΡΡΡΡΡΡ Π² Π±ΠΎΠ»ΡΡΠΈΠ½ΡΡΠ²Π΅ ΡΡΡΠ°Π½ ΠΠ²ΡΠΎΠΏΡ ΠΊΠ°ΠΊ Π΄Π΅ΠΊΠΎΡΠ°ΡΠΈΠ²Π½ΡΠ΅, ΡΡΠΈΡΠΎΠΌΠ°ΡΠ»ΠΈΡΠ½ΡΠ΅, ΠΌΠ΅Π΄ΠΎΠ½ΠΎΡΠ½ΡΠ΅ ΠΈ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΡΠΈΠ΄Π½ΡΠ΅ ΡΠ°ΡΡΠ΅Π½ΠΈΡ. Rhododendron luteum Sweet β ΠΏΠΎΠ»ΠΈΠΌΠΎΡΡΠ½ΡΠΉ Π²ΠΈΠ΄, ΠΊΠΎΡΠΎΡΡΠΉ Π²ΡΡΡΠ΅ΡΠ°Π΅ΡΡΡ Π² Π£ΠΊΡΠ°ΠΈΠ½Π΅ ΠΊΠ°ΠΊ Π΄ΠΈΠΊΠΎΡΠ°ΡΡΡΡΠ΅Π΅ ΠΈ Π΄Π΅ΠΊΠΎΡΠ°ΡΠΈΠ²Π½ΠΎΠ΅ ΡΠ°ΡΡΠ΅Π½ΠΈΠ΅. Π₯ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΈΠΉ ΡΠΎΡΡΠ°Π² ΡΠΎΠ΄ΠΎΠ΄Π΅Π½Π΄ΡΠΎΠ½Π° ΠΆΠ΅Π»ΡΠΎΠ³ΠΎ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½, ΠΏΡΠ΅ΠΈΠΌΡΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎ, ΡΡΠΈΡΠ½ΡΠΌΠΈ ΠΌΠ°ΡΠ»Π°ΠΌΠΈ, ΡΠ»Π°Π²ΠΎΠ½ΠΎΠΈΠ΄Π°ΠΌΠΈ, Π³ΠΈΠ΄ΡΠΎΠΊΡΠΈΠΊΠΎΡΠΈΡΠ½ΡΠΌΠΈ ΠΈ ΠΎΡΠ³Π°Π½ΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ ΠΊΠΈΡΠ»ΠΎΡΠ°ΠΌΠΈ, Π²Π΅ΡΠ΅ΡΡΠ²Π°ΠΌΠΈ ΡΡΠΈΡΠ΅ΡΠΏΠ΅Π½ΠΎΠ²ΠΎΠΉ ΠΈ ΠΊΡΠΌΠ°ΡΠΈΠ½ΠΎΠ²ΠΎΠΉ ΠΏΡΠΈΡΠΎΠ΄Ρ. ΠΠΈΡΡΡΡ ΡΠΈΡΠΎΠΊΠΎ ΠΈΡΠΏΠΎΠ»ΡΠ·ΡΡΡ Π² Π½Π°ΡΠΎΠ΄Π½ΠΎΠΉ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½Π΅ ΠΊΠ°ΠΊ ΠΌΠΎΡΠ΅Π³ΠΎΠ½Π½ΠΎΠ΅, ΠΏΠΎΡΠΎΠ³ΠΎΠ½Π½ΠΎΠ΅, Π²ΡΠΆΡΡΠ΅Π΅, ΡΠ°Π½ΠΎΠ·Π°ΠΆΠΈΠ²Π»ΡΡΡΠ΅Π΅, ΠΏΡΠΎΡΠΈΠ²ΠΎΠ²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΠ΅ ΠΈ Π±ΠΎΠ»Π΅ΡΡΠΎΠ»ΡΡΡΠ΅Π΅ ΡΡΠ΅Π΄ΡΡΠ²ΠΎ. ΠΡΠ΅Π΄Π²Π°ΡΠΈΡΠ΅Π»ΡΠ½ΡΠΉ Π°Π½Π°Π»ΠΈΠ· Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΠ½ΡΡ
Π΄Π°Π½Π½ΡΡ
ΠΏΠΎΠΊΠ°Π·Π°Π», ΡΡΠΎ Π² ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΠΌΠΎΡΡΠΎΠ»ΠΎΠ³ΠΎ-Π°Π½Π°ΡΠΎΠΌΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΡΡΠΎΠ΅Π½ΠΈΡ Π»ΠΈΡΡΡΠ΅Π² ΡΠΎΠ΄ΠΎΠ΄Π΅Π½Π΄ΡΠΎΠ½Π° ΠΆΠ΅Π»ΡΠΎΠ³ΠΎ ΠΈΠ·ΡΡΠ΅Π½Ρ Π΅Π³ΠΎ ΡΡΡΡΠΊΡΡΡΠ½ΠΎ-ΡΠΎΠ»ΠΈΠ°ΡΠ½ΡΠ΅ ΠΏΡΠΈΠ·Π½Π°ΠΊΠΈ Π² ΡΡΠ»ΠΎΠ²ΠΈΡΡ
ΠΏΡΠΎΠΈΠ·ΡΠ°ΡΡΠ°Π½ΠΈΡ ΡΡΠΎΠ³ΠΎ ΡΠΊΠΎΡΠΈΠΏΠ° Π² Π£ΠΊΡΠ°ΠΈΠ½Π΅. ΠΠ°ΡΠΈ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈΡΡ Ρ ΡΠ΅Π»ΡΡ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ ΠΌΠ°ΠΊΡΠΎΡΠΊΠΎΠΏΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΈ ΠΌΠΈΠΊΡΠΎΡΠΊΠΎΠΏΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΡΠΈΠ·Π½Π°ΠΊΠΎΠ² Π»ΠΈΡΡΡΠ΅Π² ΡΡΠΎΠ³ΠΎ Π²ΠΈΠ΄Π° Π΄Π»Ρ ΡΡΠ°Π½Π΄Π°ΡΡΠΈΠ·Π°ΡΠΈΠΈ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΠΎΠ³ΠΎ ΡΠ°ΡΡΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΡΡΡΡΡ ΠΈ ΡΠ°Π·ΡΠ°Π±ΠΎΡΠΊΠΈ ΠΌΠ΅ΡΠΎΠ΄ΠΈΠΊΠΈ ΠΊΠΎΠ½ΡΡΠΎΠ»Ρ ΠΊΠ°ΡΠ΅ΡΡΠ²Π°.Π¦Π΅Π»Ρ ΡΠ°Π±ΠΎΡΡ. ΠΡΠΎΠ²Π΅ΡΡΠΈ ΠΈΠ΄Π΅Π½ΡΠΈΡΠΈΠΊΠ°ΡΠΈΡ Π»ΠΈΡΡΡΠ΅Π² Rhododendron luteum (L.) Sweet ΠΏΠΎ ΠΌΠ°ΠΊΡΠΎ- ΠΈ ΠΌΠΈΠΊΡΠΎΡΠΊΠΎΠΏΠΈΡΠ΅ΡΠΊΠΈΠΌ ΠΏΡΠΈΠ·Π½Π°ΠΊΠ°ΠΌ. Π£ΡΡΠ°Π½ΠΎΠ²ΠΈΡΡ ΠΎΡΠ½ΠΎΠ²Π½ΡΠ΅ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΡΠΈΠ·Π½Π°ΠΊΠΈ Π»ΠΈΡΡΡΠ΅Π².ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΠ±ΡΠ΅ΠΊΡΠ°ΠΌΠΈ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ Π±ΡΠ»ΠΈ ΠΎΠ±ΡΠ°Π·ΡΡ Π»ΠΈΡΡΡΠ΅Π² ΡΠΎΠ΄ΠΎΠ΄Π΅Π½Π΄ΡΠΎΠ½Π° ΠΆΠ΅Π»ΡΠΎΠ³ΠΎ, ΡΠΎΠ±ΡΠ°Π½Π½ΡΡ
Π² ΠΏΠ΅ΡΠΈΠΎΠ΄ ΠΌΠ°ΡΡΠΎΠ²ΠΎΠ³ΠΎ ΡΠ²Π΅ΡΠ΅Π½ΠΈΡ. ΠΠΈΠΊΡΠΎΡΠΊΠΎΠΏΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈ Π½Π° ΡΡΡΡΠ΅, ΡΠΈΠΊΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΌ Π² ΡΠΌΠ΅ΡΠΈ ΡΠΏΠΈΡΡ-Π³Π»ΠΈΡΠ΅ΡΠΈΠ½-Π²ΠΎΠ΄Π° (1 : 1 : 1). Π ΡΠ°Π±ΠΎΡΠ΅ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π»ΠΈ ΡΠΎΡΠΎΠ°ΠΏΠΏΠ°ΡΠ°Ρ OLYMPUS Lens FE-140, ΠΌΠΈΠΊΡΠΎΡΠΊΠΎΠΏ ΠΠΠ-6, ΠΌΠΈΠΊΡΠΎΡΠΊΠΎΠΏ ΠΠΈΠΎΠ»Π°-Π.Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ ΠΈ ΠΈΡ
ΠΎΠ±ΡΡΠΆΠ΄Π΅Π½ΠΈΠ΅. ΠΠΏΡΠ΅Π΄Π΅Π»Π΅Π½Ρ ΠΎΡΠ½ΠΎΠ²Π½ΡΠ΅ ΠΌΠΎΡΡΠΎΠ»ΠΎΠ³ΠΎ-Π°Π½Π°ΡΠΎΠΌΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΡΠΈΠ·Π½Π°ΠΊΠΈ Π»ΠΈΡΡΡΠ΅Π² ΡΠΎΠ΄ΠΎΠ΄Π΅Π½Π΄ΡΠΎΠ½Π° ΠΆΠ΅Π»ΡΠΎΠ³ΠΎ. Π ΠΌΠ°ΠΊΡΠΎΡΠΊΠΎΠΏΠΈΡΠ΅ΡΠΊΠΈΠΌ ΠΏΡΠΈΠ·Π½Π°ΠΊΠ°ΠΌ ΠΎΡΠ½Π΅ΡΠ΅Π½Ρ ΠΏΡΠΎΡΡΡΠ΅ ΠΊΠΎΡΠΎΡΠΊΠΎΡΠ΅ΡΠ΅ΡΠΊΠΎΠ²ΡΠ΅ Π»ΠΈΡΡΡΡ Ρ ΠΊΠΎΠΆΠΈΡΡΠΎΠΉ, ΡΠ΅Π»ΠΎΡΡΠ½ΠΎΠΉ Π»ΠΈΡΡΠΎΠ²ΠΎΠΉ ΠΏΠ»Π°ΡΡΠΈΠ½ΠΊΠΎΠΉ Ρ ΡΠ΅Π»ΡΠ½ΡΠΌ ΠΊΡΠ°Π΅ΠΌ, Π·Π°ΠΎΡΡΡΠ΅Π½Π½ΠΎΠΉ Π²Π΅ΡΡ
ΡΡΠΊΠΎΠΉ, ΠΊΠ»ΠΈΠ½ΠΎΠ²ΠΈΠ΄Π½ΠΎΠΉ ΠΎΡΠ½ΠΎΠ²ΠΎΠΉ, ΠΏΠ΅ΡΠΈΡΡΡΠΌ ΠΆΠΈΠ»ΠΊΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ; ΠΊ ΠΌΠΈΠΊΡΠΎΡΠΊΠΎΠΏΠΈΡΠ΅ΡΠΊΠΈΠΌ β Π΄ΠΎΡΠ·ΠΎΠ²Π΅Π½ΡΡΠ°Π»ΡΠ½ΡΠΉ ΡΠΈΠΏ ΡΡΡΠΎΠ΅Π½ΠΈΡ Π»ΠΈΡΡΠΎΠ²ΠΎΠΉ ΠΏΠ»Π°ΡΡΠΈΠ½ΠΊΠΈ. ΠΠ»Π΅ΡΠΊΠΈ Π²Π΅ΡΡ
Π½Π΅ΠΉ ΡΠΏΠΈΠ΄Π΅ΡΠΌΡ ΠΊΡΡΠΏΠ½ΡΠ΅, ΡΠΎΠ½ΠΊΠΎΡΡΠ΅Π½Π½ΡΠ΅, ΠΈΠ·Π²ΠΈΠ»ΠΈΡΡΠΎΡΡΠ΅Π½Π½ΡΠ΅, Π±Π΅Π· ΡΡΡΡΠΈΡ, ΠΏΠΎΠΊΡΡΡΡΠ΅ ΡΠΎΠ»ΡΡΡΠΌ ΡΠ»ΠΎΠ΅ΠΌ ΠΊΡΡΠΈΠ½Π°; ΠΊΠ»Π΅ΡΠΊΠΈ Π½ΠΈΠΆΠ½Π΅ΠΉ ΡΠΏΠΈΠ΄Π΅ΡΠΌΡ ΡΠ»Π°Π±ΠΎ ΠΈΠ·Π²ΠΈΠ»ΠΈΡΡΠΎΡΡΠ΅Π½Π½ΡΠ΅; ΡΡΡΡΠΈΡΠ½ΡΠΉ Π°ΠΏΠΏΠ°ΡΠ°Ρ ΠΏΠ°ΡΠ°ΡΠΈΡΠ½ΠΎΠ³ΠΎ ΡΠΈΠΏΠ°, ΡΠΈΠΏΠΈΡΠ½ΡΠΉ Π΄Π»Ρ Π°Π±Π°ΠΊΡΠΈΠ°Π»ΡΠ½ΠΎΠΉ ΡΠΏΠΈΠ΄Π΅ΡΠΌΡ, ΠΏΡΠΈΡΡΡΡΡΠ²ΡΡΡ ΠΊΡΠΎΡΡΠΈΠ΅ ΠΈ ΠΆΠ΅Π»Π΅Π·ΠΈΡΡΡΠ΅ ΡΡΠΈΡ
ΠΎΠΌΡ. ΠΠ΅Π»Π΅Π·ΠΈΡΡΡΠ΅ Π±ΡΠ»Π°Π²ΠΎΠ²ΠΈΠ΄Π½ΡΠ΅ ΡΠΌΠ΅ΡΠ³Π΅Π½ΡΡ Π½Π° ΠΌΠ½ΠΎΠ³ΠΎΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠΉ ΠΏΠΎΠ΄ΡΡΠ°Π²ΠΊΠ΅, ΠΊΠ»Π΅ΡΠΊΠΈ ΠΊΠΎΡΠΎΡΠΎΠΉ Π½Π°ΠΊΠ°ΠΏΠ»ΠΈΠ²Π°ΡΡ ΠΆΠ΅Π»ΡΠΎΠ²Π°ΡΠΎ-ΠΊΠΎΡΠΈΡΠ½Π΅Π²ΡΠΉ ΡΠ΅ΠΊΡΠ΅Ρ, ΡΠ΅ΠΊΡΠ΅ΡΠΈΡΡΡΡΠ°Ρ Π³ΠΎΠ»ΠΎΠ²ΠΊΠ° ΠΎΠ²Π°Π»ΡΠ½ΠΎ-ΡΠΈΠ»ΠΈΠ½Π΄ΡΠΈΡΠ΅ΡΠΊΠ°Ρ, ΠΌΠ½ΠΎΠ³ΠΎΠΊΠ»Π΅ΡΠΎΡΠ½Π°Ρ Ρ ΡΠ΅ΠΌΠ½ΡΠΌ ΡΠΎΠ΄Π΅ΡΠΆΠΈΠΌΡΠΌ. ΠΡΠΎΡΡΠΈΠ΅ Π²ΠΎΠ»ΠΎΡΠΊΠΈ ΡΡΠ΅Ρ
ΡΠ°Π·Π½ΠΎΠ²ΠΈΠ΄Π½ΠΎΡΡΠ΅ΠΉ: ΠΏΡΠ΅ΠΎΠ±Π»Π°Π΄Π°ΡΡ 1-2-ΠΊΠ»Π΅ΡΠΎΡΠ½ΡΠ΅, Π΄Π»ΠΈΠ½Π½ΡΠ΅, Π·Π°Π³Π½ΡΡΡΠ΅, ΠΎΡΡΡΠΎΠΊΠΎΠ½Π΅ΡΠ½ΡΠ΅, ΡΠ΅ΠΆΠ΅ Π²ΡΡΡΠ΅ΡΠ°ΡΡΡΡ ΠΏΡΡΠΌΠΎΡΡΠ΅Π½Π½ΡΠ΅ Π²ΠΎΠ»ΠΎΡΠΊΠΈ Ρ ΡΠ°ΡΡΠΈΡΠ΅Π½Π½ΠΎΠΉ ΠΎΡΠ½ΠΎΠ²ΠΎΠΉ ΠΈ Π΄Π»ΠΈΠ½Π½ΡΠ΅, ΠΏΡΡΠΌΠΎΡΡΠ΅Π½Π½ΡΠ΅ ΠΈ ΡΠΎΠ½ΠΊΠΎΡΡΠ΅Π½Π½ΡΠ΅. Π§Π΅ΡΠ΅Π½ΠΎΠΊ ΠΎΠΊΡΡΠ³Π»ΠΎ-ΡΡΠ΅ΡΠ³ΠΎΠ»ΡΠ½ΡΠΉ Π½Π° ΠΏΠΎΠΏΠ΅ΡΠ΅ΡΠ½ΠΎΠΌ ΡΠ°Π·ΡΠ΅Π·Π΅, ΡΠΏΠΈΠ΄Π΅ΡΠΌΡ ΠΏΠΎΠ΄ΡΡΠΈΠ»Π°Π΅Ρ ΡΠ³Π»ΠΎΠ²Π°Ρ ΠΊΠΎΠ»Π»Π΅Π½Ρ
ΠΈΠΌΠ°; Π² ΠΏΠ°ΡΠ΅Π½Ρ
ΠΈΠΌΠ½ΡΡ
ΠΊΠ»Π΅ΡΠΊΠ°Ρ
ΡΠ°ΡΡΡΠ΅ ΠΊΡΠΈΡΡΠ°Π»Π»Ρ ΠΎΠΊΡΠ°Π»Π°ΡΠ° ΠΊΠ°Π»ΡΡΠΈΡ β Π΄ΡΡΠ·Ρ ΠΈ ΠΏΡΠΈΠ·ΠΌΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΊΡΠΈΡΡΠ°Π»Π»Ρ.ΠΡΠ²ΠΎΠ΄Ρ. ΠΠΎΠ»ΡΡΠ΅Π½Π½ΡΠ΅ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΡ ΠΈΠ·ΡΡΠ΅Π½ΠΈΡ ΠΌΠ°ΠΊΡΠΎΡΠΊΠΎΠΏΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΈ ΠΌΠΈΠΊΡΠΎΡΠΊΠΎΠΏΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΡΠΈΠ·Π½Π°ΠΊΠΎΠ² Π»ΠΈΡΡΡΠ΅Π² ΡΠΎΠ΄ΠΎΠ΄Π΅Π½Π΄ΡΠΎΠ½Π° ΠΆΠ΅Π»ΡΠΎΠ³ΠΎ Π±ΡΠ΄ΡΡ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½Ρ Π΄Π»Ρ ΡΡΠ°Π½Π΄Π°ΡΡΠΈΠ·Π°ΡΠΈΠΈ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΠΎΠ³ΠΎ ΡΠ°ΡΡΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΡΡΡΡΡ ΠΈ ΡΠ°Π·ΡΠ°Π±ΠΎΡΠΊΠΈ ΠΌΠ΅ΡΠΎΠ΄ΠΈΠΊΠΈ ΠΊΠΎΠ½ΡΡΠΎΠ»Ρ ΠΊΠ°ΡΠ΅ΡΡΠ²Π°.ΠΠΊΡΡΠ°Π»ΡΠ½ΡΡΡΡ. Π ΠΎΠ΄ΠΎΠ΄Π΅Π½Π΄ΡΠΎΠ½ΠΈ Ρ ΠΎΠ΄Π½ΠΈΠΌΠΈ Π· Π½Π°ΠΉΠΏΠΎΠΏΡΠ»ΡΡΠ½ΡΡΠΈΡ
ΡΠΎΡΠ»ΠΈΠ½, ΡΠΎ ΡΠΈΡΠΎΠΊΠΎ ΠΊΡΠ»ΡΡΠΈΠ²ΡΡΡΡΡΡ Ρ Π±ΡΠ»ΡΡΠΎΡΡΡ ΠΊΡΠ°ΡΠ½ ΠΠ²ΡΠΎΠΏΠΈ ΡΠΊ Π΄Π΅ΠΊΠΎΡΠ°ΡΠΈΠ²Π½Ρ, Π΅ΡΡΡΠΎΠΎΠ»ΡΠΉΠ½Ρ, ΠΌΠ΅Π΄ΠΎΠ½ΠΎΡΠ½Ρ ΡΠ° ΡΠ½ΡΠ΅ΠΊΡΠΈΡΠΈΠ΄Π½Ρ ΡΠΎΡΠ»ΠΈΠ½ΠΈ. Rhododendron luteum Sweet β ΠΏΠΎΠ»ΡΠΌΠΎΡΡΠ½ΠΈΠΉ Π²ΠΈΠ΄, ΡΠΊΠΈΠΉ Π·ΡΡΡΡΡΡΠ°ΡΡΡΡΡ Π² Π£ΠΊΡΠ°ΡΠ½Ρ ΡΠΊ Π΄ΠΈΠΊΠΎΡΠΎΡΠ»Π° ΡΠ° Π΄Π΅ΠΊΠΎΡΠ°ΡΠΈΠ²Π½Π° ΡΠΎΡΠ»ΠΈΠ½Π°. Π₯ΡΠΌΡΡΠ½ΠΈΠΉ ΡΠΊΠ»Π°Π΄ ΡΠΎΠ΄ΠΎΠ΄Π΅Π½Π΄ΡΠΎΠ½Ρ ΠΆΠΎΠ²ΡΠΎΠ³ΠΎ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½ΠΈΠΉ ΠΏΠ΅ΡΠ΅Π²Π°ΠΆΠ½ΠΎ Π΅ΡΡΡΠ½ΠΈΠΌΠΈ ΠΎΠ»ΡΡΠΌΠΈ, ΡΠ»Π°Π²ΠΎΠ½ΠΎΡΠ΄Π°ΠΌΠΈ, Π³ΡΠ΄ΡΠΎΠΊΡΠΈΠΊΠΎΡΠΈΡΠ½ΠΈΠΌΠΈ ΡΠ° ΠΎΡΠ³Π°Π½ΡΡΠ½ΠΈΠΌΠΈ ΠΊΠΈΡΠ»ΠΎΡΠ°ΠΌΠΈ, ΡΠ΅ΡΠΎΠ²ΠΈΠ½Π°ΠΌΠΈ ΡΡΠΈΡΠ΅ΡΠΏΠ΅Π½ΠΎΠ²ΠΎΡ ΡΠ° ΠΊΡΠΌΠ°ΡΠΈΠ½ΠΎΠ²ΠΎΡ ΠΏΡΠΈΡΠΎΠ΄ΠΈ. ΠΠΈΡΡΠΊΠΈ ΡΠΈΡΠΎΠΊΠΎ Π²ΠΈΠΊΠΎΡΠΈΡΡΠΎΠ²ΡΡΡΡ Ρ Π½Π°ΡΠΎΠ΄Π½ΡΠΉ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½Ρ ΡΠΊ ΡΠ΅ΡΠΎΠ³ΡΠ½Π½ΠΈΠΉ, ΠΏΠΎΡΠΎΠ³ΡΠ½Π½ΠΈΠΉ, Π²`ΡΠΆΡΡΠΈΠΉ, ΡΠ°Π½ΠΎΠ·Π°Π³ΠΎΡΠ²Π°Π»ΡΠ½ΠΈΠΉ, ΠΏΡΠΎΡΠΈΠ·Π°ΠΏΠ°Π»ΡΠ½ΠΈΠΉ ΡΠ° Π±ΠΎΠ»Π΅ΡΠ°ΠΌΡΠ²Π°Π»ΡΠ½ΠΈΠΉ Π·Π°ΡΡΠ±. ΠΠΎΠΏΠ΅ΡΠ΅Π΄Π½ΡΠΉ Π°Π½Π°Π»ΡΠ· Π»ΡΡΠ΅ΡΠ°ΡΡΡΠ½ΠΈΡ
Π΄Π°Π½ΠΈΡ
ΠΏΠΎΠΊΠ°Π·Π°Π², ΡΠΎ Π² ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΡ Π²ΠΈΠ²ΡΠ΅Π½Π½Ρ ΠΌΠΎΡΡΠΎΠ»ΠΎΠ³ΠΎ-Π°Π½Π°ΡΠΎΠΌΡΡΠ½ΠΎΡ Π±ΡΠ΄ΠΎΠ²ΠΈ Π»ΠΈΡΡΠΊΡΠ² ΡΠΎΠ΄ΠΎΠ΄Π΅Π½Π΄ΡΠΎΠ½Ρ ΠΆΠΎΠ²ΡΠΎΠ³ΠΎ Π²ΠΈΡΠ²Π»Π΅Π½Ρ ΠΉΠΎΠ³ΠΎ ΡΡΡΡΠΊΡΡΡΠ½ΠΎ-ΡΠΎΠ»ΡΠ°ΡΠ½Ρ ΠΎΠ·Π½Π°ΠΊΠΈ ΡΠΎΠ΄ΠΎ ΡΠΌΠΎΠ² Π·ΡΠΎΡΡΠ°Π½Π½Ρ ΡΡΠΎΠ³ΠΎ Π΅ΠΊΠΎΡΠΈΠΏΡ Π² Π£ΠΊΡΠ°ΡΠ½Ρ. ΠΠ°ΡΡ Π΄ΠΎΡΠ»ΡΠ΄ΠΆΠ΅Π½Π½Ρ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈΡΡ Π· ΠΌΠ΅ΡΠΎΡ Π²ΠΈΠΊΠΎΡΠΈΡΡΠ°Π½Π½Ρ ΠΌΠ°ΠΊΡΠΎΡΠΊΠΎΠΏΡΡΠ½ΠΈΡ
ΡΠ° ΠΌΡΠΊΡΠΎΡΠΊΠΎΠΏΡΡΠ½ΠΈΡ
ΠΎΠ·Π½Π°ΠΊ Π»ΠΈΡΡΠΊΡΠ² ΡΡΠΎΠ³ΠΎ Π²ΠΈΠ΄Ρ Π΄Π»Ρ ΡΡΠ°Π½Π΄Π°ΡΡΠΈΠ·Π°ΡΡΡ Π»ΡΠΊΠ°ΡΡΡΠΊΠΎΡ ΡΠΎΡΠ»ΠΈΠ½Π½ΠΎΡ ΡΠΈΡΠΎΠ²ΠΈΠ½ΠΈ ΡΠ° ΡΠΎΠ·ΡΠΎΠ±ΠΊΠΈ ΠΌΠ΅ΡΠΎΠ΄ΠΈΠΊΠΈ ΠΊΠΎΠ½ΡΡΠΎΠ»Ρ ΡΠΊΠΎΡΡΡ.ΠΠ΅ΡΠ° ΡΠΎΠ±ΠΎΡΠΈ. ΠΡΠΎΠ²Π΅ΡΡΠΈ ΡΠ΄Π΅Π½ΡΠΈΡΡΠΊΠ°ΡΡΡ Π»ΠΈΡΡΠΊΡΠ² Rhododendron luteum (L.) Sweet Π·Π° ΠΌΠ°ΠΊΡΠΎ- ΡΠ° ΠΌΡΠΊΡΠΎΡΠΊΠΎΠΏΡΡΠ½ΠΈΠΌΠΈ ΠΎΠ·Π½Π°ΠΊΠ°ΠΌΠΈ. ΠΡΡΠ°Π½ΠΎΠ²ΠΈΡΠΈ ΠΎΡΠ½ΠΎΠ²Π½Ρ Π΄ΡΠ°Π³Π½ΠΎΡΡΠΈΡΠ½Ρ ΠΎΠ·Π½Π°ΠΊΠΈ Π»ΠΈΡΡΡ.ΠΠ°ΡΠ΅ΡΡΠ°Π»ΠΈ ΡΠ° ΠΌΠ΅ΡΠΎΠ΄ΠΈ. ΠΠ±βΡΠΊΡΠ°ΠΌΠΈ Π΄ΠΎΡΠ»ΡΠ΄ΠΆΠ΅Π½Π½Ρ Π±ΡΠ»ΠΈ Π·ΡΠ°Π·ΠΊΠΈ Π»ΠΈΡΡΠΊΡΠ² ΡΠΎΠ΄ΠΎΠ΄Π΅Π½Π΄ΡΠΎΠ½Ρ ΠΆΠΎΠ²ΡΠΎΠ³ΠΎ, Π·ΡΠ±ΡΠ°Π½ΠΈΡ
Ρ ΠΏΠ΅ΡΡΠΎΠ΄ ΠΌΠ°ΡΠΎΠ²ΠΎΠ³ΠΎ ΡΠ²ΡΡΡΠ½Π½Ρ. ΠΡΠΊΡΠΎΡΠΊΠΎΠΏΡΡΠ½Ρ Π΄ΠΎΡΠ»ΡΠ΄ΠΆΠ΅Π½Π½Ρ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈ Π½Π° ΡΠΈΡΠΎΠ²ΠΈΠ½Ρ, ΡΡΠΊΡΠΎΠ²Π°Π½ΡΠΉ Ρ ΡΡΠΌΡΡΡ ΡΠΏΠΈΡΡ-Π³Π»ΡΡΠ΅ΡΠΈΠ½-Π²ΠΎΠ΄Π° (1 : 1 : 1). Π£ ΡΠΎΠ±ΠΎΡΡ Π²ΠΈΠΊΠΎΡΠΈΡΡΠΎΠ²ΡΠ²Π°Π»ΠΈ ΡΠΎΡΠΎΠ°ΠΏΠ°ΡΠ°Ρ OLYMPUS Lens FE-140, ΠΌΡΠΊΡΠΎΡΠΊΠΎΠΏ ΠΠΠ-6, ΠΌΡΠΊΡΠΎΡΠΊΠΎΠΏ ΠΠΠΠΠΠ-Π.Π Π΅Π·ΡΠ»ΡΡΠ°ΡΠΈ ΡΠ° ΡΡ
ΠΎΠ±Π³ΠΎΠ²ΠΎΡΠ΅Π½Π½Ρ. ΠΠΈΠ·Π½Π°ΡΠ΅Π½Ρ ΠΎΡΠ½ΠΎΠ²Π½Ρ ΠΌΠΎΡΡΠΎΠ»ΠΎΠ³ΠΎ-Π°Π½Π°ΡΠΎΠΌΡΡΠ½Ρ ΠΎΠ·Π½Π°ΠΊΠΈ Π»ΠΈΡΡΠΊΡΠ² ΡΠΎΠ΄ΠΎΠ΄Π΅Π½Π΄ΡΠΎΠ½Ρ ΠΆΠΎΠ²ΡΠΎΠ³ΠΎ. ΠΠΎ ΠΌΠ°ΠΊΡΠΎΡΠΊΠΎΠΏΡΡΠ½ΠΈΡ
ΠΎΠ·Π½Π°ΠΊ Π²ΡΠ΄Π½Π΅ΡΠ΅Π½ΠΎ β ΠΏΡΠΎΡΡΡ ΠΊΠΎΡΠΎΡΠΊΠΎΡΠ΅ΡΠ΅ΡΠΊΠΎΠ²Ρ Π»ΠΈΡΡΠΊΠΈ Π· ΡΠΊΡΡΡΡΡΠΎΡ, ΡΡΠ»ΡΡΠ½ΠΎΡ Π»ΠΈΡΡΠΊΠΎΠ²ΠΎΡ ΠΏΠ»Π°ΡΡΠΈΠ½ΠΊΠΎΡ Π· ΡΡΠ»ΡΡΠ½ΠΈΠΌ ΠΊΡΠ°ΡΠΌ, Π·Π°Π³ΠΎΡΡΡΠ΅Π½ΠΎΡ Π²Π΅ΡΡ
ΡΠ²ΠΊΠΎΡ, ΠΊΠ»ΠΈΠ½ΠΎΠΏΠΎΠ΄ΡΠ±Π½ΠΎΡ ΠΎΡΠ½ΠΎΠ²ΠΎΡ, ΠΏΠ΅ΡΠΈΡΡΠΈΠΌ ΠΆΠΈΠ»ΠΊΡΠ²Π°Π½Π½ΡΠΌ; Π΄ΠΎ ΠΌΡΠΊΡΠΎΡΠΊΠΎΠΏΡΡΠ½ΠΈΡ
β Π΄ΠΎΡΠ·ΠΎΠ²Π΅Π½ΡΡΠ°Π»ΡΠ½ΠΈΠΉ ΡΠΈΠΏ Π±ΡΠ΄ΠΎΠ²ΠΈ Π»ΠΈΡΡΠΊΠΎΠ²ΠΎΡ ΠΏΠ»Π°ΡΡΠΈΠ½ΠΊΠΈ; ΠΊΠ»ΡΡΠΈΠ½ΠΈ Π²Π΅ΡΡ
Π½ΡΠΎΡ Π΅ΠΏΡΠ΄Π΅ΡΠΌΠΈ Π²Π΅Π»ΠΈΠΊΠΎΠΊΠ»ΡΡΠΈΠ½Π½Ρ, ΡΠΎΠ½ΠΊΠΎΡΡΡΠ½Π½Ρ, Π·Π²ΠΈΠ²ΠΈΡΡΠΎΡΡΡΠ½Π½Ρ Π±Π΅Π· ΠΏΡΠΎΠ΄ΠΈΡ
ΡΠ², Π²ΠΊΡΠΈΡΡ ΡΠΎΠ²ΡΡΠΈΠΌ ΡΠ°ΡΠΎΠΌ ΠΊΡΡΠΈΠ½Ρ; ΠΊΠ»ΡΡΠΈΠ½ΠΈ Π½ΠΈΠΆΠ½ΡΠΎΡ Π΅ΠΏΡΠ΄Π΅ΡΠΌΠΈ ΡΠ»Π°Π±ΠΊΠΎ Π·Π²ΠΈΠ²ΠΈΡΡΠΎΡΡΡΠ½Π½Ρ; ΠΏΡΠΎΠ΄ΠΈΡ
ΠΎΠ²ΠΈΠΉ Π°ΠΏΠ°ΡΠ°Ρ ΠΏΠ°ΡΠ°ΡΠΈΡΠ½ΠΎΠ³ΠΎ ΡΠΈΠΏΡ, ΡΠΈΠΏΠΎΠ²ΠΈΠΉ Π΄Π»Ρ Π°Π±Π°ΠΊΡΡΠ°Π»ΡΠ½ΠΎΡ Π΅ΠΏΡΠ΄Π΅ΡΠΌΠΈ, Π½Π°ΡΠ²Π½Ρ ΠΊΡΠΈΡΡΡ ΡΠ° Π·Π°Π»ΠΎΠ·ΠΈΡΡΡ ΡΡΠΈΡ
ΠΎΠΌΠΈ. ΠΠ°Π»ΠΎΠ·ΠΈΡΡΡ Π±ΡΠ»Π°Π²ΠΎΠΏΠΎΠ΄ΡΠ±Π½Ρ Π΅ΠΌΠ΅ΡΠ³Π΅Π½ΡΡ Π½Π° Π±Π°Π³Π°ΡΠΎΠΊΠ»ΡΡΠΈΠ½Π½ΡΠΉ ΠΏΡΠ΄ΡΡΠ°Π²ΡΡ, ΠΊΠ»ΡΡΠΈΠ½ΠΈ ΡΠΊΠΎΡ Π½Π°ΠΊΠΎΠΏΠΈΡΡΡΡΡ ΠΆΠΎΠ²ΡΡΠ²Π°ΡΠΎ-Π±ΡΡΠ½Π°ΡΠ½ΠΈΠΉ ΡΠ΅ΠΊΡΠ΅Ρ, ΡΠ΅ΠΊΡΠ΅ΡΡΡΡΠ° Π³ΠΎΠ»ΠΎΠ²ΠΊΠ° ΠΎΠ²Π°Π»ΡΠ½ΠΎ-ΡΠΈΠ»ΡΠ½Π΄ΡΠΈΡΠ½Π°, Π±Π°Π³Π°ΡΠΎΠΊΠ»ΡΡΠΈΠ½Π½Π° Π· ΡΠ΅ΠΌΠ½ΠΈΠΌ Π²ΠΌΡΡΡΠΎΠΌ. ΠΡΠΈΡΡΡ Π²ΠΎΠ»ΠΎΡΠΊΠΈ ΡΡΡΠΎΡ
ΡΡΠ·Π½ΠΎΠ²ΠΈΠ΄ΡΠ²: ΠΏΠ΅ΡΠ΅Π²Π°ΠΆΠ°ΡΡΡ 1-2-ΠΊΠ»ΡΡΠΈΠ½Π½Ρ, Π΄ΠΎΠ²Π³Ρ, Π·Π°Π³Π½ΡΡΡ, Π³ΠΎΡΡΡΠΎΠΊΡΠ½ΡΠ΅Π²Ρ, ΡΡΠ΄ΡΠ΅ Π·ΡΡΡΡΡΡΠ°ΡΡΡΡΡ ΠΏΡΡΠΌΠΎΡΡΡΠ½Π½Ρ Π²ΠΎΠ»ΠΎΡΠΊΠΈ Π· ΡΠΎΠ·ΡΠΈΡΠ΅Π½ΠΎΡ ΠΎΡΠ½ΠΎΠ²ΠΎΡ ΡΠ° Π΄ΠΎΠ²Π³Ρ, ΠΏΡΡΠΌΠΎΡΡΡΠ½Π½Ρ Ρ ΡΠΎΠ½ΠΊΠΎΡΡΡΠ½Π½Ρ. Π§Π΅ΡΠ΅ΡΠΎΠΊ ΠΎΠΊΡΡΠ³Π»ΠΎ-ΡΡΠΈΠΊΡΡΠ½ΠΈΠΉ Π½Π° ΠΏΠΎΠΏΠ΅ΡΠ΅ΡΠ½ΠΎΠΌΡ ΡΠΎΠ·ΡΡΠ·Ρ, Π΅ΠΏΡΠ΄Π΅ΡΠΌΡ ΠΏΡΠ΄ΡΡΠ΅Π»ΡΡ ΠΊΡΡΠΎΠ²Π° ΠΊΠΎΠ»Π΅Π½Ρ
ΡΠΌΠ°; Π² ΠΏΠ°ΡΠ΅Π½Ρ
ΡΠΌΠ½ΠΈΡ
ΠΊΠ»ΡΡΠΈΠ½Π°Ρ
ΡΠ°ΡΡΡ ΠΊΡΠΈΡΡΠ°Π»ΠΈ ΠΎΠΊΡΠ°Π»Π°ΡΡ ΠΊΠ°Π»ΡΡΡΡ β Π΄ΡΡΠ·ΠΈ ΡΠ° ΠΏΡΠΈΠ·ΠΌΠ°ΡΠΈΡΠ½Ρ ΠΊΡΠΈΡΡΠ°Π»ΠΈ.ΠΠΈΡΠ½ΠΎΠ²ΠΊΠΈ. ΠΡΡΠΈΠΌΠ°Π½Ρ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΈ Π²ΠΈΠ²ΡΠ΅Π½Π½Ρ ΠΌΠ°ΠΊΡΠΎΡΠΊΠΎΠΏΡΡΠ½ΠΈΡ
ΡΠ° ΠΌΡΠΊΡΠΎΡΠΊΠΎΠΏΡΡΠ½ΠΈΡ
ΠΎΠ·Π½Π°ΠΊ Π»ΠΈΡΡΠΊΡΠ² ΡΠΎΠ΄ΠΎΠ΄Π΅Π½Π΄ΡΠΎΠ½Ρ ΠΆΠΎΠ²ΡΠΎΠ³ΠΎ Π±ΡΠ΄ΡΡΡ Π²ΠΈΠΊΠΎΡΠΈΡΡΠ°Π½Ρ Π΄Π»Ρ ΡΡΠ°Π½Π΄Π°ΡΡΠΈΠ·Π°ΡΡΡ Π»ΡΠΊΠ°ΡΡΡΠΊΠΎΡ ΡΠΎΡΠ»ΠΈΠ½Π½ΠΎΡ ΡΠΈΡΠΎΠ²ΠΈΠ½ΠΈ ΡΠ° ΡΠΎΠ·ΡΠΎΠ±ΠΊΠΈ ΠΌΠ΅ΡΠΎΠ΄ΠΈΠΊΠΈ ΠΊΠΎΠ½ΡΡΠΎΠ»Ρ ΡΠΊΠΎΡΡΡ
Immunological features of allergic rhinitis in combination with chronic rhinosinusitis of bacterial etiology
Rhinitis is a socially significant and widespread disease. Often, various forms of rhinitis are combined, and thus cause severe clinical manifestations, insufficient effectiveness of drug treatment, as well as difficulties in differential diagnosis. It is known that a significant number of patients have a combination of allergic rhinitis (AR) with chronic rhinosinusitis of bacterial etiology. This condition is based on a chronic multifactorial inflammatory process of the nasal mucosa, which determines the steady progression of the disease. Of interest is the study of a number of allergo-immunological parameters in nasal secretions in order to assess local inflammation and changes in mucosal immunity in allergic rhinitis in combination with chronic rhinosinusitis of bacterial etiology (AR with HRSBE). Mucosal immunity and biological mediators determine local inflammation and pathophysiological response to etiological factors in the immunopathogenesis of AR with CRSBE. The work carried out the determination of the level of cytokines: IL-4, IL-10, TGF-Γ’1, IFNΓ£ spontaneous and induced; immunoglobulins: IgA, IgM, IgG, sIgA in nasal secretions; leukotrienes: LT C4/ D4/E4 and LTB4 in plasma and total IgE in serum in patients with AR with moderate-severity HRSBE without exacerbation. It has been shown that the leading role in the formation of the inflammatory process in AR with CRSBE belongs to cytokines: IL-4, IL-10, TGF-Γ’; immunoglobulins: IgM, sIgA; leukotrienes: LT C4/D4/E4 and LTB4 and total IgE. Induced cytokine production largely reflects the reserve capabilities of immunocompetent cells in response to the action of a pathogenic factor. The results obtained are associated with the persistent course of allergic and infectious inflammation and the progression of the disease. Thus, cytokines: IL-4, IL-10, TGF-Γ’1; immunoglobulins: IgM, sIgA, IgE total and LT C4/D4/E4 and LTB4 make a significant contribution to pathogenetic mechanisms, determining the clinical course of AR with CRSBE, and can serve as biological markers of the activity of the pathological process. Undoubtedly, the immune mechanisms in the combined pathological inflammatory reaction from the mucosa in AR with HRSBE are complex and multifaceted. A personalized approach to the treatment of patients with AR with CRSBE is determined by the severity and intensity of the inflammatory reaction, as well as mucosal mucosal immunity disorders. The study of the role and significance of the production of leading cytokines, immunoglobulins in nasal secretions, as well as leukotrienes and total IgE in the blood will help the doctor in determining the tactics and duration of pharmacotherapy
Comparative Pharmacoepidemiological Assessment of Antihypertensive Drugs Administration Structure in Pregnant Women in Routine Medical Practice in Kursk and Chisinau
Aim. To study the structure of antihypertensive drugs prescription in pregnant women in routine practice in Kursk and Chisinau.Material and methods. The study design was observational descriptive cross-sectional. Authors conducted a survey of doctors in medical organizations in Kursk and Chisinau in 2017-2018.Results. Respondents from Kursk and Chisinau preferred methyldopa in prescriptions of central alpha-adrenergic receptor agonists. Doctors from Chisinau used clonidine in 14.3% of cases. The leading place in the group of calcium channel blockers belonged to short-acting nifedipine. Among beta-blockers in Kursk, doctors most often prescribed bisoprolol (43.3%), metoprolol (21.7%) and nebivolol (13.3%), while in Chisinau the preference was given to metoprolol (32.1%), atenolol (19.6%) and bisoprolol (16.1%). From the group of diuretics, Kursk doctors mainly prescribed hydrochlorothiazide (10%), indapamide (6.7%); in Chisinau, indapamide was the leader (19.6%), hydrochlorothiazide was used less frequently (7,1%). From the class of alpha-blockers, prazosin occupied the leading position among respondents in Kursk, and terazosin in Chisinau.Conclusion. The priority drug classes in both regions were calcium channel blockers, central alpha-adrenergic receptor agonists and beta-blockers. A small number of not recommended drugs prescriptions have been registered. In general, the prescribed treatment corresponded to the current guidelines and protocols for the management of patients with arterial hypertension during pregnancy
Investigation of the correlation of allele polymorphism of renin-angiotensin system genes, nitric oxide synthase and folate cycle with the severity of ischemic stroke
Aim. To study the frequency of polymorphic gene variants encoding proteins of renin-angiotensin system [AGT Thr174Met (rs 4762), AGT Met235Thr (rs699), AGTR1 A1166C (rs5186)], endothelial factors [NOS3 C786T (rs2070744)], and folate cycle enzymes [MTHFR C677T (rs1801133)] in patients with various ischemic stroke severity.
Methods. 98 patients with ischemic stroke verified by magnetic resonance imaging and computed tomography scan of the brain, were examined. The severity of stroke was assessed by National Institutes of Health Stroke Scale. The allelic variants of genes were typified by polymerase chain reaction with the detection of amplification products in the Β«real timeΒ» mode.
Results. The analysis of genetic polymorphism frequency of renin-angiotensin system did not reveal statistically significant differences in the study groups. The polymorphism of NOSC786T gene in the study was also not associated with the severity of ischemic stroke. Among the studied polymorphic variants, only the C677T polymorphism of MTHFR gene was revealed to be reliably associated with severe course of acute cerebral ischemia.
Conclusion. C677T polymorphism of MTHFR gene is reliably associated with severe course of acute cerebral ischemia; carriage of 677T allele of MTHFR gene in the studied category of patients can cause an increased level of homocysteine and have an adverse effect on the course of acute cerebral ischemia
STUDIES ON THE ROLE OF CYTOKINES POLYMORPHISM IN PATHOGENESIS OF CHRONIC URTICARIA
Fifty patients with chronic autoimmune urticaria (CAU) and forty-eight patients with chronic idiopathic urticaria (CIU) have been examined. Blood serum contents of IL-4, IL-10 and IL-17A, spontaneous and induced cytokine production in blood cells, as well as polymorphism of IL-4 (C-589T), IL-10 (G-1082A), IL-17A (G-197A) cytokine genes has been studied. No differences have been detected when studying IL-4 levels, depending on genetic variants of IL-4 gene in patients with CAU and CIU. Increased IL-10 amounts in patients with CIU still did not show any correlations with IL-10 genotype (G-1082A). Increased IL-17A levels in patients with CAU were associated with homozygous genotype of AA in comparison to control group, and with heterozygous GA genotype, in comparison to CIU group. The revealed differences of cytokines` genes polymorphism in CAU and CIU provide a molecular-genetic evidence for different clinical forms of chronic urticaria
Development of Composition and Technology of Combination Drug with Neurally Mediated Action Β«MemofitΒ»
Aim. The aim of this work is to develop composition of combination drug in the form of hard-gelatin capsules Β«MemofitΒ», determine technological and microbiological parameters of intermediate products and ready medicinal product and develop of manufacturing process for capsules Β«MemofitΒ».Methods of the research. Investigations presented in the article were performed in accordance with the procedures described by the State Pharmacopoeia of Ukraine (SPh Ukraine).The results of the research. Necessity of the development of dietary supplement to provide special dietary properties for the purpose of regulation of functions and systems of the organism within the physiologically normal states under the nervous system dysfunction was substantiated. Results of the study of pharmaco-technological and microbiological parameters of dry extracts that are included as a compound of hard-gelatin capsules Β«MemofitΒ» were presented. Optimal technological parameters for manufacturing process of capsules Β«MemofitΒ» were proposed. Results of mass balance for a batch of capsules Β«MemofitΒ» proved rationality of selected manufacturing process were given. Technology of manufacturing process of capsules Β«MemofitΒ» was introduced into the production on the TOV βDZ βGNCLSβ.Conclusions. Possibility of the development of solid formulations in the form of capsules was established based on the obtained experimental findings of the determination of pharmaco-technological and microbiological parameters of dry extracts. It was shown that capsules Β«MemofitΒ» are used in dietary food ration as additional source of biologically active substances for promoting normalization of brain function and sleep, improvement of attentiveness. This preparation has general tonic properties and improves mental and physical efficiency. Manufacturing process and process flow chart for this medication was substantiate